{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:39:37Z","timestamp":1790552377158,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T00:00:00Z","timestamp":1658880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T00:00:00Z","timestamp":1658880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000066","name":"U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["P42-ES010337"],"award-info":[{"award-number":["P42-ES010337"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["P42-ES010337"],"award-info":[{"award-number":["P42-ES010337"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["R21-ES031849"],"award-info":[{"award-number":["R21-ES031849"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Here we show that Triclosan (TCS), a high-volume antimicrobial additive that has been detected in human breastmilk, can be efficiently transferred by lactation to newborn mice, causing significant fatty liver (FL) during the suckling period. These findings are relevant since pediatric non-alcoholic fatty liver disease (NAFLD) is escalating in the United States, with a limited mechanistic understanding. Lactational delivery stimulated hepatosteatosis, triglyceride accumulation, endoplasmic reticulum (ER) stress, signs of inflammation, and liver fibrosis. De novo lipogenesis (DNL) induced by lactational TCS exposure is shown to be mediated in a PERK-eIF2\u03b1-ATF4-PPAR\u03b1 cascade. The administration of obeticholic acid (OCA), a potent FXR agonist, as well as activation of intestinal mucosal-regenerative gp130 signaling, led to reduced liver ATF4 expression, PPAR\u03b1 signaling, and DNL when neonates were exposed to TCS. It is yet to be investigated but mother to child transmission of TCS or similar toxicants may underlie the recent increases in pediatric NAFLD.<\/jats:p>","DOI":"10.1038\/s41467-022-31947-4","type":"journal-article","created":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T10:02:42Z","timestamp":1658916162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Lactational delivery of Triclosan promotes non-alcoholic fatty liver disease in newborn mice"],"prefix":"10.1038","volume":"13","author":[{"given":"Andr\u00e9 A.","family":"Weber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira","family":"Mennillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeramie D.","family":"Watrous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Karin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9683-4226","authenticated-orcid":false,"given":"Robert H.","family":"Tukey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,27]]},"reference":[{"key":"31947_CR1","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.mayocp.2015.06.013","volume":"90","author":"EK Spengler","year":"2015","unstructured":"Spengler, E. K. & Loomba, R. Recommendations for diagnosis, referral for liver biopsy, and treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Mayo Clin. Proc. 90, 1233\u20131246 (2015).","journal-title":"Mayo Clin. Proc."},{"key":"31947_CR2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.2174\/1574887109666141216111143","volume":"9","author":"M Masarone","year":"2014","unstructured":"Masarone, M., Federico, A., Abenavoli, L., Loguercio, C. & Persico, M. Non alcoholic fatty liver: epidemiology and natural history. Rev. Recent Clin. Trials 9, 126\u2013133 (2014).","journal-title":"Rev. Recent Clin. Trials"},{"key":"31947_CR3","doi-asserted-by":"crossref","unstructured":"Kohli, R. et al. Pediatric nonalcoholic fatty liver disease: a report from the expert committee on nonalcoholic fatty liver disease (ECON). J. Pediatr. 172, 9\u201313 (2016).","DOI":"10.1016\/j.jpeds.2015.12.016"},{"key":"31947_CR4","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.cld.2015.10.003","volume":"20","author":"NP Goyal","year":"2016","unstructured":"Goyal, N. P. & Schwimmer, J. B. The progression and natural history of pediatric nonalcoholic fatty liver disease. Clin. Liver Dis. 20, 325\u2013338 (2016).","journal-title":"Clin. Liver Dis."},{"key":"31947_CR5","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1542\/peds.2006-1212","volume":"118","author":"JB Schwimmer","year":"2006","unstructured":"Schwimmer, J. B. et al. Prevalence of fatty liver in children and adolescents. Pediatrics 118, 1388\u20131393 (2006).","journal-title":"Pediatrics"},{"key":"31947_CR6","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/nrgastro.2011.273","volume":"9","author":"A Alisi","year":"2012","unstructured":"Alisi, A., Feldstein, A. E., Villani, A., Raponi, M. & Nobili, V. Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach. Nat. Rev. Gastroenterol. Hepatol. 9, 152\u2013161 (2012).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"31947_CR7","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.24001","volume":"52","author":"H Tilg","year":"2010","unstructured":"Tilg, H. & Moschen, A. R. Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis. Hepatology 52, 1836\u20131846 (2010).","journal-title":"Hepatology"},{"key":"31947_CR8","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jhep.2018.06.008","volume":"69","author":"C Lebeaupin","year":"2018","unstructured":"Lebeaupin, C. et al. Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease. J. Hepatol. 69, 927\u2013947 (2018).","journal-title":"J. Hepatol."},{"key":"31947_CR9","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1053\/j.gastro.2016.06.022","volume":"151","author":"K Rahman","year":"2016","unstructured":"Rahman, K. et al. Loss of junctional adhesion molecule a promotes severe steatohepatitis in mice on a diet high in saturated fat, fructose, and cholesterol. Gastroenterology 151, 733\u2013746.e712 (2016).","journal-title":"Gastroenterology"},{"key":"31947_CR10","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/s42255-020-0261-2","volume":"2","author":"J Todoric","year":"2020","unstructured":"Todoric, J. et al. Fructose stimulated de novo lipogenesis is promoted by inflammation. Nat. Metab. 2, 1034\u20131045 (2020).","journal-title":"Nat. Metab."},{"key":"31947_CR11","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.15252\/embr.201642195","volume":"17","author":"K Pakos-Zebrucka","year":"2016","unstructured":"Pakos-Zebrucka, K. et al. The integrated stress response. EMBO Rep. 17, 1374\u20131395 (2016).","journal-title":"EMBO Rep."},{"key":"31947_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.cell.2014.03.012","volume":"157","author":"RM Evans","year":"2014","unstructured":"Evans, R. M. & Mangelsdorf, D. J. Nuclear receptors, RXR, and the Big Bang. Cell 157, 255\u2013266 (2014).","journal-title":"Cell"},{"key":"31947_CR13","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1136\/gutjnl-2015-310798","volume":"65","author":"A Montagner","year":"2016","unstructured":"Montagner, A. et al. Liver PPARalpha is crucial for whole-body fatty acid homeostasis and is protective against NAFLD. Gut 65, 1202\u20131214 (2016).","journal-title":"Gut"},{"key":"31947_CR14","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1073\/pnas.1700172114","volume":"114","author":"X Zhang","year":"2017","unstructured":"Zhang, X. et al. Ablation of cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic steatosis and fibrosis. Proc. Natl Acad. Sci. USA 114, 3181\u20133185 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"31947_CR15","doi-asserted-by":"publisher","first-page":"25350","DOI":"10.1074\/jbc.M113.470526","volume":"288","author":"G Xiao","year":"2013","unstructured":"Xiao, G. et al. ATF4 protein deficiency protects against high fructose-induced hypertriglyceridemia in mice. J. Biol. Chem. 288, 25350\u201325361 (2013).","journal-title":"J. Biol. Chem."},{"key":"31947_CR16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-physiol-021115-105339","volume":"78","author":"FM Fisher","year":"2016","unstructured":"Fisher, F. M. & Maratos-Flier, E. Understanding the physiology of FGF21. Annu Rev. Physiol. 78, 223\u2013241 (2016).","journal-title":"Annu Rev. Physiol."},{"key":"31947_CR17","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.2337\/db15-1637","volume":"65","author":"X Chen","year":"2016","unstructured":"Chen, X. et al. Hepatic ATF6 increases fatty acid oxidation to attenuate hepatic steatosis in mice through peroxisome proliferator-activated receptor \u03b1. Diabetes 65, 1904\u20131915 (2016).","journal-title":"Diabetes"},{"key":"31947_CR18","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/hep.24685","volume":"55","author":"A Marmugi","year":"2012","unstructured":"Marmugi, A. et al. Low doses of bisphenol A induce gene expression related to lipid synthesis and trigger triglyceride accumulation in adult mouse liver. Hepatology 55, 395\u2013407 (2012).","journal-title":"Hepatology"},{"key":"31947_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.taap.2018.10.011","volume":"363","author":"H Shi","year":"2019","unstructured":"Shi, H. et al. Polychlorinated biphenyl exposures differentially regulate hepatic metabolism and pancreatic function: Implications for nonalcoholic steatohepatitis and diabetes. Toxicol. Appl Pharm. 363, 22\u201333 (2019).","journal-title":"Toxicol. Appl Pharm."},{"key":"31947_CR20","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1021\/es500495p","volume":"48","author":"RU Halden","year":"2014","unstructured":"Halden, R. U. On the need and speed of regulating triclosan and triclocarban in the United States. Environ. Sci. Technol. 48, 3603\u20133611 (2014).","journal-title":"Environ. Sci. Technol."},{"key":"31947_CR21","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1146\/annurev-pharmtox-010715-103417","volume":"56","author":"MF Yueh","year":"2016","unstructured":"Yueh, M. F. & Tukey, R. H. Triclosan: a widespread environmental toxicant with many biological effects. Annu. Rev. Pharmacol. Toxicol. 56, 251\u2013272 (2016).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"31947_CR22","doi-asserted-by":"publisher","first-page":"17200","DOI":"10.1073\/pnas.1419119111","volume":"111","author":"MF Yueh","year":"2014","unstructured":"Yueh, M. F. et al. The commonly used antimicrobial additive triclosan is a liver tumor promoter. Proc. Natl Acad. Sci. USA 111, 17200\u201317205 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"31947_CR23","doi-asserted-by":"crossref","unstructured":"Yueh, M. F. et al. Triclosan leads to dysregulation of the metabolic regulator FGF21 exacerbating high fat diet-induced nonalcoholic fatty liver disease. Proc. Natl Acad. Sci. USA 117, 31259\u201331266 (2020).","DOI":"10.1073\/pnas.2017129117"},{"key":"31947_CR24","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/j.chemosphere.2011.08.009","volume":"85","author":"LM Toms","year":"2011","unstructured":"Toms, L. M. et al. Triclosan in individual human milk samples from Australia. Chemosphere 85, 1682\u20131686 (2011).","journal-title":"Chemosphere"},{"key":"31947_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.fct.2006.08.009","volume":"45","author":"AD Dayan","year":"2007","unstructured":"Dayan, A. D. Risk assessment of triclosan [Irgasan] in human breast milk. Food Chem. Toxicol. 45, 125\u2013129 (2007).","journal-title":"Food Chem. Toxicol."},{"key":"31947_CR26","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3109\/10408441003667514","volume":"40","author":"JV Rodricks","year":"2010","unstructured":"Rodricks, J. V., Swenberg, J. A., Borzelleca, J. F., Maronpot, R. R. & Shipp, A. M. Triclosan: a critical review of the experimental data and development of margins of safety for consumer products. Crit. Rev. Toxicol. 40, 422\u2013484 (2010).","journal-title":"Crit. Rev. Toxicol."},{"key":"31947_CR27","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S0140-6736(15)01024-7","volume":"387","author":"CG Victora","year":"2016","unstructured":"Victora, C. G. et al. Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet 387, 475\u2013490 (2016).","journal-title":"Lancet"},{"key":"31947_CR28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.scitotenv.2006.08.007","volume":"372","author":"M Allmyr","year":"2006","unstructured":"Allmyr, M., Adolfsson-Erici, M., McLachlan, M. S. & Sandborgh-Englund, G. Triclosan in plasma and milk from Swedish nursing mothers and their exposure via personal care products. Sci. Total Environ. 372, 87\u201393 (2006).","journal-title":"Sci. Total Environ."},{"key":"31947_CR29","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1080\/15287390600631706","volume":"69","author":"G Sandborgh-Englund","year":"2006","unstructured":"Sandborgh-Englund, G., Adolfsson-Erici, M., Odham, G. & Ekstrand, J. Pharmacokinetics of triclosan following oral ingestion in humans. J. Toxicol. Environ. Health A 69, 1861\u20131873 (2006).","journal-title":"J. Toxicol. Environ. Health A"},{"key":"31947_CR30","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1172\/JCI99009","volume":"128","author":"S Softic","year":"2018","unstructured":"Softic, S. et al. Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling. J. Clin. Invest 128, 1199 (2018).","journal-title":"J. Clin. Invest"},{"key":"31947_CR31","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jcmgh.2020.07.006","volume":"11","author":"A Saeed","year":"2021","unstructured":"Saeed, A. et al. Impaired hepatic vitamin A metabolism in NAFLD mice leading to vitamin A accumulation in hepatocytes. Cell Mol. Gastroenterol. Hepatol. 11, 309\u2013325.e303 (2021).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"31947_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4056-8","volume":"18","author":"Z Liu","year":"2018","unstructured":"Liu, Z. et al. MCM family in HCC: MCM6 indicates adverse tumor features and poor outcomes and promotes S\/G2 cell cycle progression. BMC Cancer 18, 200 (2018).","journal-title":"BMC Cancer"},{"key":"31947_CR33","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature24302","volume":"551","author":"S Shalapour","year":"2017","unstructured":"Shalapour, S. et al. Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity. Nature 551, 340\u2013345 (2017).","journal-title":"Nature"},{"key":"31947_CR34","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1053\/j.semdp.2006.04.002","volume":"22","author":"EM Brunt","year":"2005","unstructured":"Brunt, E. M. Nonalcoholic steatohepatitis: pathologic features and differential diagnosis. Semin Diagn. Pathol. 22, 330\u2013338 (2005).","journal-title":"Semin Diagn. Pathol."},{"key":"31947_CR35","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-1-4939-2895-8_5","volume":"872","author":"T Kuo","year":"2015","unstructured":"Kuo, T., McQueen, A., Chen, T. C. & Wang, J. C. Regulation of glucose homeostasis by glucocorticoids. Adv. Exp. Med. Biol. 872, 99\u2013126 (2015).","journal-title":"Adv. Exp. Med. Biol."},{"key":"31947_CR36","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00109-016-1477-1","volume":"95","author":"A Salminen","year":"2017","unstructured":"Salminen, A., Kauppinen, A. & Kaarniranta, K. FGF21 activates AMPK signaling: impact on metabolic regulation and the aging process. J. Mol. Med. (Berl., Ger.) 95, 123\u2013131 (2017).","journal-title":"J. Mol. Med. (Berl., Ger.)"},{"key":"31947_CR37","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.molmet.2015.07.006","volume":"4","author":"JG Okun","year":"2015","unstructured":"Okun, J. G. et al. Molecular regulation of urea cycle function by the liver glucocorticoid receptor. Mol. Metab. 4, 732\u2013740 (2015).","journal-title":"Mol. Metab."},{"key":"31947_CR38","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nature01667","volume":"423","author":"P Puigserver","year":"2003","unstructured":"Puigserver, P. et al. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature 423, 550\u2013555 (2003).","journal-title":"Nature"},{"key":"31947_CR39","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ccr.2014.07.001","volume":"26","author":"H Nakagawa","year":"2014","unstructured":"Nakagawa, H. et al. ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development. Cancer Cell 26, 331\u2013343 (2014).","journal-title":"Cancer Cell"},{"key":"31947_CR40","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nm.3760","volume":"21","author":"S Fang","year":"2015","unstructured":"Fang, S. et al. Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance. Nat. Med. 21, 159\u2013165 (2015).","journal-title":"Nat. Med."},{"key":"31947_CR41","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1053\/j.gastro.2013.05.042","volume":"145","author":"S Mudaliar","year":"2013","unstructured":"Mudaliar, S. et al. Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease. Gastroenterology 145, 574\u2013582.e571 (2013).","journal-title":"Gastroenterology"},{"key":"31947_CR42","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1289\/ehp.10768","volume":"116","author":"AM Calafat","year":"2008","unstructured":"Calafat, A. M., Ye, X., Wong, L. Y., Reidy, J. A. & Needham, L. L. Urinary concentrations of triclosan in the U.S. population: 2003-2004. Environ. Health Perspect. 116, 303\u2013307 (2008).","journal-title":"Environ. Health Perspect."},{"key":"31947_CR43","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41575-018-0089-3","volume":"16","author":"E Piccinin","year":"2019","unstructured":"Piccinin, E., Villani, G. & Moschetta, A. Metabolic aspects in NAFLD, NASH and hepatocellular carcinoma: the role of PGC1 coactivators. Nat. Rev. Gastroenterol. Hepatol. 16, 160\u2013174 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"31947_CR44","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1159\/000276561","volume":"25","author":"K Wang","year":"2010","unstructured":"Wang, K. et al. SGK1-dependent intestinal tumor growth in APC-deficient mice. Cell Physiol. Biochem. 25, 271\u2013278 (2010).","journal-title":"Cell Physiol. Biochem."},{"key":"31947_CR45","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1016\/j.febslet.2014.04.012","volume":"588","author":"BC Low","year":"2014","unstructured":"Low, B. C. et al. YAP\/TAZ as mechanosensors and mechanotransducers in regulating organ size and tumor growth. FEBS Lett. 588, 2663\u20132670 (2014).","journal-title":"FEBS Lett."},{"key":"31947_CR46","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.envres.2017.04.015","volume":"156","author":"TM Etzel","year":"2017","unstructured":"Etzel, T. M. et al. Urinary triclosan concentrations during pregnancy and birth outcomes. Environ. Res. 156, 505\u2013511 (2017).","journal-title":"Environ. Res."},{"key":"31947_CR47","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1289\/ehp.1408187","volume":"123","author":"TE Arbuckle","year":"2015","unstructured":"Arbuckle, T. E. et al. Exposure to free and conjugated forms of bisphenol A and triclosan among pregnant women in the MIREC cohort. Environ. Health Perspect. 123, 277\u2013284 (2015).","journal-title":"Environ. Health Perspect."},{"key":"31947_CR48","doi-asserted-by":"crossref","unstructured":"Yang, H. et al. A common antimicrobial additive increases colonic inflammation and colitis-associated colon tumorigenesis in mice. Sci. Transl. Med. 10, eaan4116 (2018).","DOI":"10.1126\/scitranslmed.aan4116"},{"key":"31947_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27762-y","volume":"13","author":"J Zhang","year":"2022","unstructured":"Zhang, J. et al. Microbial enzymes induce colitis by reactivating triclosan in the mouse gastrointestinal tract. Nat. Commun. 13, 136 (2022).","journal-title":"Nat. Commun."},{"key":"31947_CR50","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00795-013-0016-1","volume":"46","author":"M Fujii","year":"2013","unstructured":"Fujii, M. et al. A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma. Med. Mol. Morphol. 46, 141\u2013152 (2013).","journal-title":"Med. Mol. Morphol."},{"key":"31947_CR51","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cell.2018.08.020","volume":"175","author":"JY Kim","year":"2018","unstructured":"Kim, J. Y. et al. ER stress drives lipogenesis and steatohepatitis via caspase-2 activation of S1P. Cell 175, 133\u2013145.e115 (2018).","journal-title":"Cell"},{"key":"31947_CR52","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.jhep.2019.12.016","volume":"72","author":"HY Ma","year":"2020","unstructured":"Ma, H. Y. et al. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease. J. Hepatol. 72, 946\u2013959 (2020).","journal-title":"J. Hepatol."},{"key":"31947_CR53","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.cmet.2008.04.011","volume":"7","author":"S Oyadomari","year":"2008","unstructured":"Oyadomari, S., Harding, H. P., Zhang, Y., Oyadomari, M. & Ron, D. Dephosphorylation of translation initiation factor 2\u03b1 enhances glucose tolerance and attenuates hepatosteatosis in mice. Cell Metab. 7, 520\u2013532 (2008).","journal-title":"Cell Metab."},{"key":"31947_CR54","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ebiom.2018.01.008","volume":"28","author":"N Boudaba","year":"2018","unstructured":"Boudaba, N. et al. AMPK re-activation suppresses hepatic steatosis but its downregulation does not promote fatty liver development. EBioMedicine 28, 194\u2013209 (2018).","journal-title":"EBioMedicine"},{"key":"31947_CR55","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1126\/science.aay0542","volume":"367","author":"P Zhao","year":"2020","unstructured":"Zhao, P. et al. An AMPK-caspase-6 axis controls liver damage in nonalcoholic steatohepatitis. Science 367, 652\u2013660 (2020).","journal-title":"Science"},{"key":"31947_CR56","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/labinvest.2011.55","volume":"91","author":"M Aharoni-Simon","year":"2011","unstructured":"Aharoni-Simon, M., Hann-Obercyger, M., Pen, S., Madar, Z. & Tirosh, O. Fatty liver is associated with impaired activity of PPARgamma-coactivator 1alpha (PGC1alpha) and mitochondrial biogenesis in mice. Lab Invest. 91, 1018\u20131028 (2011).","journal-title":"Lab Invest."},{"key":"31947_CR57","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","volume":"62","author":"M Pawlak","year":"2015","unstructured":"Pawlak, M., Lefebvre, P. & Staels, B. Molecular mechanism of PPAR\u03b1 action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease. J. Hepatol. 62, 720\u2013733 (2015).","journal-title":"J. Hepatol."},{"key":"31947_CR58","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature14228","volume":"519","author":"K Taniguchi","year":"2015","unstructured":"Taniguchi, K. et al. A gp130-Src-YAP module links inflammation to epithelial regeneration. Nature 519, 57\u201362 (2015).","journal-title":"Nature"},{"key":"31947_CR59","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-1-4939-8769-6_2","volume":"1862","author":"KA Lagerborg","year":"2019","unstructured":"Lagerborg, K. A., Watrous, J. D., Cheng, S. & Jain, M. High-throughput measure of bioactive lipids using non-targeted mass spectrometry. Methods Mol. Biol. 1862, 17\u201335 (2019).","journal-title":"Methods Mol. Biol."},{"key":"31947_CR60","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.chembiol.2018.11.015","volume":"26","author":"JD Watrous","year":"2019","unstructured":"Watrous, J. D. et al. Directed non-targeted mass spectrometry and chemical networking for discovery of eicosanoids and related oxylipins. Cell Chem. Biol. 26, 433\u2013442.e434 (2019).","journal-title":"Cell Chem. Biol."},{"key":"31947_CR61","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"31947_CR62","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1139\/y59-099","volume":"37","author":"EG Bligh","year":"1959","unstructured":"Bligh, E. G. & Dyer, W. J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911\u2013917 (1959).","journal-title":"Can. J. Biochem. Physiol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31947-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31947-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31947-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T13:10:27Z","timestamp":1669295427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31947-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,27]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["31947"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-31947-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.05.20.492880","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,27]]},"assertion":[{"value":"23 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4346"}}